New Study on ME/CFS Reveals Insights into Muscle Function

Understanding Post-Exertional Malaise

Recent research has shed light on the perplexing question of why individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) experience post-exertional malaise, despite having muscle cells that appear normal. The study suggests a potential biological mechanism underlying the muscle fatigue and cramping that significantly impact those suffering from ME/CFS.

Cellular Stress and Energy Deficiency

The findings indicate that some patients may be experiencing cellular stress, which interferes with the function of a protein called WASF3. This interference hampers the body’s ability to convert oxygen and glucose into energy, resulting in a slower replenishment of energy stores in the muscles compared to healthy individuals.

Insights from Dr. Paul Hwang

We had the opportunity to speak with Dr. Paul Hwang, the principal investigator of the study and a researcher at the US National Heart, Lung, and Blood Institute. Dr. Hwang has dedicated over 30 years to advancing research in cardiovascular and cancer genetics. He completed his MD/PhD at Johns Hopkins Medical School in 1993.

The Research Journey

Medical News Bulletin (MNB): Why ME/CFS? Did you approach this project with the hypothesis of a connection between WASF3 and ME/CFS, or did it develop unexpectedly?

Dr. Hwang: It was a prepared accident. Our initial research focused on the regulation of mitochondria by the mutated TP53 gene, linked to Li-Fraumeni syndrome (LFS). One patient with LFS also exhibited chronic fatigue symptoms, which contradicted our previous findings. This discrepancy prompted us to explore the potential relationship between the fatigue symptoms and the mutated p53 gene.

Continuing Interest in ME/CFS

MNB: Do you maintain an ongoing interest in ME/CFS?

Dr. Hwang: Yes, after identifying WASF3 in mitochondria, we are keen to investigate its role in ME/CFS further.

Surprising Findings

MNB: What aspect of the results surprised you the most?

Dr. Hwang: The challenge of identifying potential genes involved in complex conditions like ME/CFS was surprising. It required the convergence of various factors, including the accumulation of background information, patient samples from NIH ME/CFS researchers Drs. Avindra Nath and Brian Walitt, a proactive patient, and contributions from talented scientists like Drs. Ping-yuan Wang and Jin Ma.

Exploring ER Stress and Inflammation

MNB: Some studies suggest links between ER stress, inflammation, and various diseases. What might cause ER stress, and is chronic inflammation a factor?

Dr. Hwang: Those are great questions, but I would be speculating. However, I believe there is substantial evidence connecting inflammation and immune mechanisms to ME/CFS. My understanding is that cells can become distressed, potentially due to viral infections, leading to a stress response that may damage mitochondria.

Impact on Diagnosis and Treatment

MNB: How do you hope your study will influence the diagnosis and treatment of ME/CFS? What further research is necessary?

Dr. Hwang: Regarding WASF3 as a diagnostic marker, I want to clarify that we do not consider WASF3 the cause of ME/CFS but rather a factor contributing to muscle energy deficiency. We noted increased WASF3 levels in a small subset of 14 ME/CFS patients, which may not apply to all. Currently, there are no clinical tests for WASF3 levels; our measurements were conducted on skin and muscle tissue samples, which are not feasible for routine clinical use. More research is essential to validate our findings and explore the possibility of targeting WASF3 in ME/CFS patients to improve muscle bioenergetics.

Future Directions

MNB: Will you continue to investigate WASF3 and ME/CFS? Any insights into your next steps?

Dr. Hwang: Yes, we are in the exploratory phase and aim to determine if targeting WASF3 in ME/CFS patients can address the bioenergetic defects we identified.

Message to ME/CFS Patients

MNB: Do you have any message for our readers or individuals living with ME/CFS?

Dr. Hwang: Our lab is committed to advancing our findings, recognizing that treatment is a top priority.

If you seek assistance in understanding the original research, consider joining us at MNB: Journal Club for a detailed breakdown of the evidence.

We extend our gratitude to the NIH media center and Dr. Hwang for their time and insights.